Health product recall

Glucovision (Citrate) (2020-05-11)

Starting date:
May 11, 2020
Type of communication:
Drug Recall
Subcategory:
Radiopharmaceuticals
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
Healthcare Professionals, Hospitals, General Public
Identification number:
RA-73167

Last updated: 2020-05-21

Summary

  • Product:
    Glucovision (Citrate) 453 GBq/vial

Reason

Affected lot contains ethanol levels outside of the labelled claim.

Depth of distribution

Healthcare establishments

Affected products

Glucovision (Citrate) 453 GBq/vial

DIN, NPN, DIN-HIM

DIN 02328771

Dosage form

Solution

Strength

Fludeoxyglucose 18F 453 GBq/vial

Lot or serial number

T-200511FDG-1

Companies

Recalling Firm

Centre for Probe Development and Commercialization (CPDC)

1280 Main St. W. NRB-A316

Hamilton

L8S 4K1

Ontario

CANADA

Marketing Authorization Holder

Centre for Probe Development and Commercialization (CPDC)

1280 Main St. W. NRB-A316

Hamilton

L8S 4K1

Ontario

CANADA